DK1022022T3 - Præparat til inhibering af forhöjet blodsukkerniveau eller sænkning af blodsukkerniveau - Google Patents

Præparat til inhibering af forhöjet blodsukkerniveau eller sænkning af blodsukkerniveau

Info

Publication number
DK1022022T3
DK1022022T3 DK99123173T DK99123173T DK1022022T3 DK 1022022 T3 DK1022022 T3 DK 1022022T3 DK 99123173 T DK99123173 T DK 99123173T DK 99123173 T DK99123173 T DK 99123173T DK 1022022 T3 DK1022022 T3 DK 1022022T3
Authority
DK
Denmark
Prior art keywords
blood sugar
lowering
preparation
inhibiting
levels
Prior art date
Application number
DK99123173T
Other languages
English (en)
Inventor
Futoshi Matsuyama
Original Assignee
Matsuyama Futoshi C O Use Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18405294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1022022(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Matsuyama Futoshi C O Use Tech filed Critical Matsuyama Futoshi C O Use Tech
Application granted granted Critical
Publication of DK1022022T3 publication Critical patent/DK1022022T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99123173T 1998-12-09 1999-11-23 Præparat til inhibering af forhöjet blodsukkerniveau eller sænkning af blodsukkerniveau DK1022022T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10349667A JP2000169384A (ja) 1998-12-09 1998-12-09 血糖値上昇抑制乃至下降用組成物

Publications (1)

Publication Number Publication Date
DK1022022T3 true DK1022022T3 (da) 2006-01-09

Family

ID=18405294

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99123173T DK1022022T3 (da) 1998-12-09 1999-11-23 Præparat til inhibering af forhöjet blodsukkerniveau eller sænkning af blodsukkerniveau

Country Status (7)

Country Link
US (3) US6485760B2 (da)
EP (1) EP1022022B1 (da)
JP (1) JP2000169384A (da)
AT (1) ATE303805T1 (da)
DE (1) DE69927125T2 (da)
DK (1) DK1022022T3 (da)
ES (1) ES2245812T3 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60015847T2 (de) * 1999-05-25 2005-10-27 Use Techno Corp., Fukuchiyama Flüssige Zubereitung zum Verdampfen gegen Erhöhung des Blutzuckerspiegels und Verdampfer für dieselbe
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
AU2002219858A1 (en) * 2000-11-28 2002-06-11 Avon Products Inc. Anti-aging cosmetic composition and method of application
JP2002255837A (ja) * 2001-03-01 2002-09-11 Mikimoto Pharmaceut Co Ltd アルドースレダクターゼ阻害剤
CN1578669A (zh) * 2001-08-31 2005-02-09 俄亥俄州立大学 治疗高血糖症个体的组合物和方法
US6908632B1 (en) * 2002-04-19 2005-06-21 Pharmanex, Llc Blood glucose modulating compositions and methods
JP4094332B2 (ja) * 2002-04-23 2008-06-04 丸善製薬株式会社 水分散性又は水溶解性のバナバ葉抽出物組成物
JP2005029570A (ja) 2003-06-16 2005-02-03 Tokiwa Shokubutsu Kagaku Kenkyusho:Kk コロソリン酸の製造方法
JP2005126414A (ja) * 2003-09-11 2005-05-19 Kiyotoshi Oshiro 吸収を高める生薬成分含有組成物及びその製造方法。
US20050137259A1 (en) * 2003-09-22 2005-06-23 Use- Techno Corporation Insulin secretion potentiator
US20050142270A1 (en) * 2003-09-22 2005-06-30 Use- Techno Corporation Functional sweetener
US20050143464A1 (en) * 2003-09-22 2005-06-30 Use-Techno Corporation Insulin secretion potentiator
US20070093552A1 (en) * 2003-09-22 2007-04-26 Futoshi Matsuyama Early insulin secretion stimulator
US7125571B2 (en) 2003-11-25 2006-10-24 D & E Pharmaceuticals, Inc. Herbal formulation
WO2005063228A1 (ja) * 2003-12-26 2005-07-14 Use-Techno Corporation 耐糖能改善剤
US20050267055A1 (en) * 2003-12-26 2005-12-01 Use-Techno Corporation Agent for improvement of glucose tolerance
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
JP4922550B2 (ja) * 2004-03-16 2012-04-25 株式会社東洋新薬 コロソリン酸高含有バナバ葉抽出物の製造方法
WO2005099486A1 (ja) * 2004-04-15 2005-10-27 San-Ei Gen F.F.I., Inc. バナバ抽出物の調製方法
JP2005350453A (ja) * 2004-05-14 2005-12-22 Toyo Shinyaku:Kk バナバ葉の水難溶性成分
WO2006012015A2 (en) * 2004-06-29 2006-02-02 Oregon Health And Science University Methods and compositions for nerve regeneration
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
CN1303096C (zh) * 2004-10-12 2007-03-07 中国药科大学 科罗索酸和山楂酸的制备方法
WO2006054370A1 (en) * 2004-11-16 2006-05-26 Use-Techno Corporation Gluconeogenesis inhibiting agent
US7574353B2 (en) * 2004-11-18 2009-08-11 Lsi Logic Corporation Transmit/receive data paths for voice-over-internet (VoIP) communication systems
US20060198907A1 (en) * 2004-12-22 2006-09-07 Alex Moffett Pharmaceutical, therapeutic, and dietary compositions derived from Lagerstroemia speciosa L. plant
CN101137344B (zh) * 2005-02-22 2011-12-21 丸善制药株式会社 头发护理品
KR100693400B1 (ko) * 2005-06-30 2007-03-09 주식회사 삼양제넥스 식물 세포 현탁 배양에 의한 코로솔릭산의 제조방법
KR100697184B1 (ko) 2006-01-06 2007-03-21 주식회사 농협고려인삼 인삼과 상엽과 바나바엽을 주재로 한 혈당강하용 기능성 식품 및 그 제조방법
US20070166321A1 (en) * 2006-01-13 2007-07-19 Bryant Villeponteau Compositions and Methods for Reducing Cholesterol and Inflammation
WO2007094497A1 (ja) * 2006-02-17 2007-08-23 Use-Techno Corporation メタボリックシンドローム改善剤
US9943409B2 (en) 2006-11-14 2018-04-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Transcatheter coronary sinus mitral valve annuloplasty procedure and coronary artery and myocardial protection device
US8211171B2 (en) 2006-11-14 2012-07-03 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Transcatheter coronary sinus mitral valve annuloplasty procedure and coronary artery and myocardial protection device
US7416750B1 (en) 2007-02-26 2008-08-26 Nbty, Inc. Composition to provide maintenance and nutritional support in glycemic control deficits
US20080268039A1 (en) * 2007-03-06 2008-10-30 Soft Gel Technologies, Inc. Loquat compositions
JP2013010715A (ja) * 2011-06-29 2013-01-17 Nippon Flour Mills Co Ltd う蝕予防剤、歯周病予防剤及び口腔用組成物
US11039923B2 (en) 2016-05-06 2021-06-22 Transmural Systems Llc Annuloplasty procedures, related devices and methods
EP3451973A4 (en) 2016-05-06 2019-12-25 Transmural Systems LLC ANNULOPLASTIC INTERVENTIONS, RELATED DEVICES AND METHODS
US11980545B2 (en) 2016-05-06 2024-05-14 Transmural Systems Llc Annuloplasty procedures, related devices and methods
WO2019046205A1 (en) 2017-08-26 2019-03-07 Macdonald, Stuart ANNULOPLASTY AND CARDIAC STIMULATION PROCEDURES, DEVICES AND ASSOCIATED METHODS
US11007059B2 (en) 2016-05-06 2021-05-18 Transmural Systems Llc Annuloplasty procedures, related devices and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544550A (en) * 1982-10-05 1985-10-01 Rodolfo Almanzor Y Method for the treatment of diabetes
JPH05310587A (ja) 1992-03-11 1993-11-22 Itouen:Kk バナバ葉抽出物と使用方法並びに抗糖尿病剤
JP3507115B2 (ja) * 1994-02-18 2004-03-15 株式会社 伊藤園 バナバ葉抽出物と抗糖尿病剤
JP3507116B2 (ja) * 1994-02-18 2004-03-15 株式会社 伊藤園 コレステロール上昇抑制作用剤

Also Published As

Publication number Publication date
JP2000169384A (ja) 2000-06-20
US20010000474A1 (en) 2001-04-26
ATE303805T1 (de) 2005-09-15
DE69927125T2 (de) 2006-05-18
DE69927125D1 (de) 2005-10-13
EP1022022B1 (en) 2005-09-07
ES2245812T3 (es) 2006-01-16
EP1022022A1 (en) 2000-07-26
US6485760B2 (en) 2002-11-26
US20010006941A1 (en) 2001-07-05
US20030008025A1 (en) 2003-01-09
US6716459B2 (en) 2004-04-06

Similar Documents

Publication Publication Date Title
DK1022022T3 (da) Præparat til inhibering af forhöjet blodsukkerniveau eller sænkning af blodsukkerniveau
CA2417089A1 (en) Palatable oral coenzyme q liquid
ATE321462T1 (de) Verbesserte pädiatrische zusammensetzung und verfahren zur ernährung und verbesserung der toleranz
NO20002306L (no) FremgangsmÕte ved økning av absorpsjon og transport av lipid- oppløselige forbindelser ved Õ bruke strukturelle glycerider
WO1997001640A3 (en) Vaccines against hepatitis c
ATE395916T1 (de) Orale methylphenidat-formulierungen mit kontrollierter/veränderter freisetzung
BR0012303A (pt) Composição de gordura
WO2006062807A3 (en) Compositions with enhanced immunogenicity
NZ297879A (en) Ondansetron and polyhydric alcohol (a sweetener) in a liquid acidic oral composition form
WO2002019972A3 (en) Stabilized ascorbic acid solutions
NO20010833L (no) Orale mukoadhesive sammensetninger inneholdende gastrointestinale aktive bestanddeler
BR9914644A (pt) Composições tamponadas para diálise
WO2000064276A3 (en) Enriched spreads
WO1999059523A3 (en) Topical pharmaceutical compositions useful for the treatment of cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis
EP2272530A3 (en) Antigenic Compositions
PT100668A (pt) Composicao farmaceutica compreendendo extractos alcoolicos de corydalis e eschsoltzia para utilizacao no tratamento de estados de agitacao e doencas dos nervos
DE69624563D1 (de) Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff
CO5180598A1 (es) Composicion para disminuir la concentracion de alcohol en la sangre, que contiene extractos de pepino y metodo para producir la misma
DE69501183D1 (de) Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung
EP1741344A3 (en) Chewing gum including a liquid sorbitol/mannitol/glycerin blend
DK0991741T3 (da) Voksestere, som er beriget med omega-3-umættede fedtsyrer, deres fremstilling og anvendelse
DK0465550T3 (da) Farmaceutisk lipidsammensætning til parenteral ernæring
EP1440687A4 (en) ANTIRADIC AND FAT COMPOSITIONS, FOODS, BEVERAGES, MEDICINAL PRODUCTS OR FEED AGENTS CONTAINING THESE ANTIRADICAS
DK0541780T3 (da)
ATE241693T1 (de) Neues anethanol enthaltend klares gegebenfalls alkoholisches getränk und trübes verdünntes getränk hergestellt durch verdünnung